scleroderma

1. It is feasible to utilize Beauveria bassiana carried by Scleroderma sichuanensis Xiao to infect Monochamus alternatus larva voluntarily.
利用川硬皮肿腿蜂携带球孢白僵菌主动感染松墨天牛幼虫的设想是可行的。

youdao

2. Scleroderma is a chronic disease that lasts many months to years.
硬皮病是一种可以持续数月至数年的疾病。

youdao

3. On our main Medical page you can find links such as What is Scleroderma?
在我们的医学网页上,你能够找到象什么是硬皮病?

youdao

4. Localized scleroderma may be associated with some autoimmune-related causes.
局限性硬皮病发病可能与自身免疫性因素有关。

youdao

5. Scleroderma is a progressive disease resulting in fibrosis of any organ system.
硬皮病是一种渐进性疾病,可累及全身任何器官,引起器官的纤维化。

youdao

6. Unfortunately, there is no proven treatment or cure for any form of scleroderma.
很遗憾的是,至今为止还没有有效的治疗方法来治愈硬皮病。

youdao

7. Objective To study the effect of VEGF on the hair growth in mice with scleroderma.
目的观察VEGF对硬皮病小鼠模型毛发生长的作用。

youdao

8. The case was diagnosed as lichen sclerosus et atrophicus with localized scleroderma .
患者诊断为硬化萎缩性苔藓合并局限性硬皮病。

youdao

9. Autoimmune: such as lupus erythematosus, rheumatoid arthritis, scleroderma, and other.
自身免疫性:如红斑狼疮、类风湿关节炎、硬皮病等。

youdao

10. However, there is increasingly strong evidence of a genetic predisposition to scleroderma.
然而,存在硬皮病遗传因素的日益增长的证据。

youdao

11. The clinical and laboratory data of 105 patients with systemic scleroderma (SSC) were analysed.
对105例系统性硬皮病患者的一般情况、临床表现作了详细分析。

youdao

12. When linear scleroderma affects the head it is sometimes referred to as scleroderma en coup DE sabre.
带状硬皮病累及头部时,有时被称为剑伤性硬皮病。

youdao

13. The goal is that better management of scleroderma as a multi-spectrum, chronic disease will be achieved.
我们的目标是更好地管理作为一个多光谱,硬皮病,慢性疾病将得以实现。

youdao

14. Its primary clinical manifestation is localized sclerosis of the skin, which is very similar to scleroderma.
该病和硬皮病的临床表现很相似,都是以局限性皮肤硬化为主要皮损表现。

youdao

15. Objective: To explore the expression and distribution of osteopontin in local lesions of scleroderma patients.
目的:探讨骨桥蛋白在硬皮病患者局部皮损表达和分布情况。

youdao

16. The microvascular modification is pathologic base of most clinical manifestation and complication of scleroderma.
微血管病变是硬皮病大部分临床表现及并发症的病理基础。

youdao

17. All of this shows that scleroderma patients with pulmonary fibrosis than before treatment significantly improved.
这些都表明硬皮病患者肺间质纤维化的程度较治疗前明显好转。

youdao

18. Objective Investigation of the effect of integrin on fibroblasts from scleroderma in the production of procollagen.
目的研究硬皮病成纤维细胞整合素表达对成纤维细胞合成原胶原的影响。

youdao

19. Objective To investigate the role of platelet-derived growth factor receptor in the development of scleroderma fibrosis.
目的探讨血小板衍生生长因子在硬皮病发病中的作用。

youdao

20. These are often used to treat conditions such as scleroderma that can cause extensive scarring and hardening of the skin.
这些都是常用的治疗条件,如硬皮病可导致广泛的疤痕和硬化的皮肤。

youdao

21. Conclusion VEGF can significantly promote the growth and regeneration of the hair follicles in the mice with scleroderma.
结论VEGF对硬皮病小鼠模型毛囊的再生有明显的促进作用。

youdao

22. Scleroderma(or progressive systemic sclerosis):Chronic disease that hardens the skin and fixes it to underlying structures.
硬皮病(亦称进行性全身硬化症):一种使皮肤变硬并固着于皮下结构的慢性皮肤病。

youdao

23. The drug decreases the inflammation that causes pulmonary fibrosis and has been used on scleroderma patients for the last 10 years.
该药能使导致肺纤维化的炎症得以减轻,在过去10年里被应用于硬皮病患者。

youdao

24. The scleroderma Society of Canada (SSC) is proud to present the largest bilingual conference on scleroderma ever held in this country.
加拿大(SSC),硬皮病会自豪地介绍在这个国家举行有史以来最大的双语硬皮病会议。

youdao

25. Pulmonary fibrosis caused by the end of the respiratory and circulatory failure in patients with scleroderma is the main factor of death.
肺间质纤维化最终所引起的呼吸循环衰竭是硬皮病患者的主要致死因素之一。

youdao

26. Systemic scleroderma is a involving skin, bones and joints, digestive, respiratory, heart, kidney, and other systems, multi-organ disease.
系统性硬皮病是一种累及皮肤、骨关节、消化道、呼吸道、心、肾等多系统、多器官的疾病。

youdao

27. Systemic scleroderma is a involving skin, bones and joints, digestive, respiratory, heart, kidney, and other systems, multi-organ disease.
系统性硬皮病是一种累及皮肤、骨关节、消化道、呼吸道、心、肾等多系统、多器官的疾病。

youdao